Abstract-Interleukin-1 receptor-associated kinase (IRAK1) is a key regulatory protein in TLR/IL1R-mediated cell activation during inflammatory response. Studies indicated that pending on the nature of the used inflammatory model, downregulation of IRAK1 may be beneficial or detrimental. However, the role of IRAK1 in affecting outcome in polymicrobial sepsis is unknown. We tested this question using an IRAK1-deficient mouse strain and cecal ligation and puncture (CLP) procedure, which is a clinically relevant rodent septic model. Sepsis-induced mortality was markedly lower in IRAK1-deficient mice (35 %) compared to WT (85 %). Sepsis-induced increases in blood IL-6 and IL-10 levels were blunted at 6 h post-CLP in IRAK1 deficiency compared to WT, but cytokine levels were similar at 20 h post-CLP. Sepsis-induced blood granulocytosis and depletion of splenic B cells were also blunted in IRAK1-deficient mice as compared to WT. Analysis of TLR-mediated cytokine responses by IRAK1-deficient and WT macrophages ex vivo indicated a TLR4-dependent downregulation of IL-6 and IL1β in IRAK1 deficiency, whereas TLR2-dependent responses were unaffected. TLR7/8-mediated IL-6, IL1β, and IL-10 production was also blunted in IRAK1 macrophages as compared to WT. The study shows that IRAK1 deficiency impacts multiple TLR-dependent pathways and decreases early cytokine responses following polymicrobial sepsis. The delayed inflammatory response caused by the lack of IRAK1 expression is beneficial, as it manifests a marked increased chance of survival after polymicrobial sepsis.
INTRODUCTION
Interleukin-1 receptor-associated kinase 1 (IRAK1) is a regulatory protein with key functions in mediating immune cell activation [1] [2] [3] . Upon certain physiological or pathological stimuli, ligands binding to TLR or IL-1R receptors initiate reorganization of the intracellular domain of the receptor protein complex with subsequent recruitment of regulatory proteins including MyD88 and IRAK4. IRAK1 also associates with the complex and becomes phosphorylated by IRAK4 [1] [2] [3] . Depending on the cell type, phosphorylated IRAK1 may become part of different signaling protein complexes including the TRAF6/TAK1/TAB1,2 complex or it may interact with interferon regulatory factors (IRFs) or Sumo proteins leading to activation of nuclear factor kappa B, MAP kinases, or IRFs with subsequent transcriptional activation of target genes [2, 3] . The regulatory role of IRAK1 in cell signaling is complex and depends not only on the initial TLR stimuli but also on the presence of redundant or interacting signaling pathways in a particular cell type. Nevertheless, because the effect of active IRAK1 promotes cell activation, it is expected that inhibition of IRAK1-dependent signaling would dampen cell activation and inflammatory responses.
After the development of IRAK1 knockout mice [4] , the effects of IRAK1 deficiency have been tested in various in vitro and in vivo systems. Studies showed impaired NFκB activation and TNFα and IL-6 production following IL-1β stimulation in vitro and in vivo [4] . Other studies indicated that IRAK1 regulates not only NFkB-and MAPK-dependent cytokine productions [5] but also IL-10 [6] and type-I interferon expression [7, 8] through not yet fully elucidated crosstalk among signaling pathways.
The impact of IRAK1 activation, or the lack of, on clinical outcome is expected to be influenced by the unique pathology of the particular inflammatory condition. Consistent with this notion, it has been shown that IRAK1 deficiency improved myocardial contractile dysfunction following burn [9, 10] and was beneficial in autoimmune conditions associated with hyperinflammation [11, 12] . Using acute endotoxicosis models, IRAK1-deficient mice presented decreased TNFα release, alleviated myocardial dysfunction, and improved survival as compared to WT [10, 13] . Exhaustion of IRAK1 activity rendered by repeated endotoxin administration was shown to mediate endotoxin tolerance [14, 15] . In contrast, IRAK-deficient mice were more susceptible to iv administration of high dose live Staphylococcus aureus than WT controls [16] . The direct clinical relevance of these observations, however, is not readily evident because high blood levels of bacterial endotoxins are seldom observed in human clinical conditions. Likewise, massive bacterial load through the blood stream, which is modeled by iv infusion of live bacteria, occurs rarely in clinical conditions especially in the absence of accompanying systemic or massive local inflammation. Therefore, it is important to further elucidate the effect of IRAK1 deficiency in clinically more relevant septic inflammatory models.
Septic peritonitis induced by the cecal ligation and puncture (CLP) procedure is accepted as a clinically relevant polymicrobial sepsis model in rodents [17] [18] [19] . CLP initiates an acute peritonitis, which leads to an inflammatory response and septicemia that is reminiscent to that observed in septic patients. Therefore, the aim of the study was to test the effect of IRAK1 deficiency in CLP-initiated sepsis. We compared sepsis-induced mortality and level of bacteremia between WT and IRAK1-deficient subjects. Differences in the systemic inflammatory response were assessed by comparing blood and organ cytokine levels. Phagocyte and lymphocyte cell composition changes in selected organs were determined to assess cell trafficking and lymphocyte dysfunction. Finally, because multiple TLR-dependent pathways are activated during in vivo sepsis, we also tested TLRinduced cytokine responses by IRAK1-deficient and WT macrophages ex vivo.
METHODS

Reagents
Endotoxin-free, cell culture-grade buffers, media, and reagents were used in the experiments. Flourochromeconjugated antibodies, assay diluents, and lysing and permeabilizing flow cytometry solutions and kits were purchased from BD Biosiences and BD Pharmingen. All other reagents and chemicals of the highest grade available were purchased from Sigma-Aldrich Co. (St. Louis, MO, USA).
Animals and CLP
Male IRAK1 deficient (−/y) and WT (+/y, 57BL6J) mice were bred in parallel colonies at our animal facility. Ten-to 16-week-old animals were used in the experiments. The initial IRAK1-deficient breeders on BL6 background were obtained from James Thomas, University of Texas Southwestern Medical Center. Animals purchased from the Jackson Laboratory were used as breeders for the WT colony.
Polymicrobial septic peritonitis was induced using the cecal ligation and puncture (CLP) model as described earlier [20, 21] . Briefly, animals were anesthetized by an ip injection of Nembutal (5 mg/100 g bw). A midline abdominal incision was made. The cecum was exposed, ligated, and punctured through opposing walls at two sites with a 20-gauge hypodermic needle. Animals were resuscitated by the subcutaneous injection of isotonic, pyrogen-free saline solution (0.04 ml/g bw) immediately postoperatively and also at 20 h post-CLP. When animals were followed for longer than 24 h, they received daily saline resuscitations at the same dose. In a pilot experiment, we compared naïve controls and sham operations (opening the abdomen and moving the intestine but no ligation or puncture) and found no remarkable increase in inflammatory markers [22] . Thus, in these experiments, we used nontreated naïve animals as controls.
The studies were performed in accordance with the Guide for the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee of the New Jersey Medical School.
Genotyping
The IRAK1 KO mutant mouse was generated by replacing a 7-kb gene with neomycin selection cassette. The deleted region included 3.5 kb of the upstream regulatory region and all of exons from 1 to 8 and a portion of exon 9 [4] . Total genomic DNA was isolated from tail clippings using the REDExtract-N-Amp Tissue PCR kit (Sigma-Aldrich). DNA was subjected to PCR amplification using forward primers complementary to the PGKneo insert or WT sequences, respectively, and a common downstream primer. Forward primers were WT: 5′-GCAAGCCAGAGCAGTACTGTG-3′ and IRAK1 KO (NEO)-F: 5′-GCCTTCTATCGCCTTCTTGACG-3′, and common reverse primer:
PCR reaction was carried out in the presence of 2 mM MgCl 2 with the following cycling: 94°C for 2 min; followed by 35 cycles of 94°C for 30 s, 58°C for 30 s, and 72°C for 2 min and 30 s; with the final elongation of 72°C for 7 min. PCR amplicons were resolved on 0.8 % agarose gels.
Blood, Splenocyte, and BM Cell Isolation and Incubations
Blood was collected into heparinized tubes via cardiac puncture from fully anesthetized animals. Following the exsanguination, femurs were collected from the same animals. Femurs were cut at the diaphyses and BM cells flushed out by repeated injections of phosphatebuffered saline (PBS) containing 10 % FBS through the bone channel. BM cells were sedimented and washed by centrifugation and suspended in a final volume to obtain 10 million/ml cells in the same PBS/FBS buffer. Next, the spleen was removed and placed into DMEM containing 10 % FBS and penicillin-streptomycin solution. Hypodermic needles were used to pull apart the splenic capsule releasing spleen cells into suspension. The cell suspension together with the remaining splenic capsule was squeezed through a 70-μm nylon mesh cell strainer. Isolated bone marrow cells or splenocytes were resuspended in DMEM containing 1 % FBS for subsequent analyses or in vitro incubations.
Macrophage Isolation and Treatments
Peritoneal macrophages were isolated as described previously [23] . Briefly, mice were injected with 2.5 ml sterile Brewer's thioglycolate broth ip. On day 4, peritoneal cells were harvested, washed repeatedly (300×g for 15 min at 4°C), and resuspended in DMEM containing 20 mM HEPES, 4 mM glutamine, penicillin-streptomycin solution, and 10 % FBS. Cells were analyzed by flow cytometry for the dual expression of macrophage markers F4/80 and CD11b. More than 95 % of cells were positive for these markers, and yields were also similar in WT and IRAK1-deficient animals. Cells were seeded into Falcon 24-well tissue culture plates (0.6×10 5 cells/well) and incubated at 37°C (95 % air/5 %CO 2 ) to allow cells to adhere for 60 min prior to administration of stimulants. Adherent cells were incubated with DMEM containing 1 % FBS and penicillin-streptomycin solution in the presence of vehicle or different TLR agonists: TLR4 (ultrapure LPS 100 ng/ ml), TLR2 (Pam3CSK4 200 ng/ml), TLR7/8 agonist (thiazoloquinoline, 2.5 μg/ml)), or opsonized heat-killed E. coli (HKB, 8 × 10 5 /ml). All agents used in the experiments were dissolved in media as vehicle, unless otherwise stated. After various treatments, the media were collected, and cytokine content was determined by enzymelinked immunoabsorbance assay (ELISA) according to the manufacturer's protocol. Standards were run on each ELISA plate and analyzed in parallel with the test samples.
Flow Cytometry
BM, blood, and spleen flow cytometry analyses and gating strategy has been described in detail previously [24] . Briefly, the number of PMNs and lymphocyte subsets in blood, spleen, and thymus was determined by the number of total cell counts and the percent distribution of CD3 (myeloid cells). Aliquots of 0.1 ml whole blood, splenocyte, or BM cell suspension were incubated with the respective markers for 15 min followed by incubation with BD FACS lysing solution (BD Biosciences) for 7 min at 37°C. Cells were washed twice with BD FACS wash buffer and then fixed with 1 % methanol-free formaldehyde. FACS acquisitions were performed in a centralized flow cytometry facility. At least 30,000 events were collected for each analysis.
Blood differentials and cell counts in BM, spleen, and thymus were determined using a computerized cell counter (HemaTrue Veterinary Hematology Analyzer, Heska Corporation, Loveland, CO, USA).
ELISAs, Enzyme Assays, and Determination of Blood Bacterial Counts
ELISA kits for IL-10, IL-6, and IL1β were purchased from BD biosciences (San Jose, CA, USA), Mip-2 (Dy452E) from R&D Systems (Minneapolis, MN, USA) . Plasma from freshly drawn heparinized blood was stored at −85°C till analysis. ELISAs were performed according to the manufacturer's protocol. All the compared samples from different genotypes were run simultaneously in duplicates on one plate. Values were determined from a calibration curve run parallel with the samples.
Bacterial counts were determined from a 0.1-ml blood sample collected under sterile conditions and diluted serially in sterile physiological saline. Each dilution (0.05 ml) was aseptically plated on trypticase blood agar plates (BD Biosciences, San Jose, CA, USA) and, after 24 h incubation at 37°C, the number of bacterial colonies was counted.
Statistical Analysis
Statistical calculations were performed using JMP software (SAS Institute Inc., Cary, NC, USA). Results were analyzed using ANOVA followed by t test for pairwise comparisons or Tukey-Kramer's test for multiple comparisons. We used the logrank test to assess survival differences among groups. Different study components were performed on six to eight different animals from each of the in vivo treatment groups unless indicated otherwise. Significant difference was concluded at p<0.05 unless otherwise noted.
RESULTS
Cecal ligation and puncture-induced sepsis (CLP) manifest many similarities to that observed in human peritonitis-induced clinical sepsis [18, 19, 25, 26] . First, we compared CLP-induced mortality between IRAK1-deficient and WT animals. Figure 1 indicates that CLP resulted in about 85 % mortality in WT mice, whereas mortality was only about 35 % in IRAK1-deficient animals. The difference in sepsis-induced mortality was statistically significant between WT and IRAK1-deficient group (p<0.001).
We also tested bacterial colony forming units in blood 20 h after CLP, which is a time point when animal loss is negligible and, thus, observations are not affected by survival bias. We found that bacteremia was similar in WT and IRAK1-deficient mice (Fig. 1 insert) . This indicated that the survival advantage in IRAK1 deficiency is likely to be associated with changes in the severity of inflammation rather than differences in bacterial load. Therefore, next, we compared blood and tissue concentrations of IL-6 and IL-10 which are important cytokine mediators of the inflammatory response during sepsis [27] [28] [29] [30] . Figure 2 indicates that blood IL-6 and IL-10 was elevated in WT mice at 6 h after CLP, whereas IRAK1-deficient mice showed negligible levels of these cytokines ( Fig. 2a and b) . In contrast, blood IL-6 and IL-10 levels were similar in WT and IRAK1-deficient mice 20 h after CLP ( Fig. 2c and d) . IL-6 and IL-10 content in lung and spleen was below detection limit at 6 h post-CLP (data not shown) and similar at 20 h post-CLP in IRAK1 and WT mice (Fig. 2e-h) .
Sepsis results in changes in immune cell composition in blood as well as immune-competent organs due to interorgan cell trafficking, cell proliferation, or apoptosis. Thus, we determined CLP-induced cell composition changes in blood and selected organs from WT and IRAK1-deficient mice at the 20 h post-CLP when animal death is still negligible (Fig. 3) . Myeloid cell content in BM was elevated in IRAK1-deficient mice as compared to WT under control nonchallenged conditions. Sepsis depleted BM myeloid as well as lymphoid cell content in WT and deficient mice similarly (Fig. 3a and b) . Sepsisinduced increase in the number of circulating neutrophils was blunted in IRAK1 animals as compared to WT, but Role of IRAK1 in early cytokine release following sepsis. Blood and tissues were collected at 6 and 20 h after CLP, and plasma cytokine content was determined using ELISA as described in "Methods". Mean±S.E.M., n=5-8 animals in each group. *Statistically significant difference as compared to control or as indicated by connecting line (p<0.05, mean±S.E.M.).
the marked depletion of circulating B cells was similar in WT and IRAK1-deficient mice ( Fig. 3c and d) . In contrast, splenic B cell content was depleted in WT but not in IRAK1-deficient septic mice (Fig. 3e) , whereas sepsis-induced changes in CD8 and CD 4 T cell content in spleen ( Fig. 3f and g ) or thymus (not shown) were similar in WT and IRAK1-deficient animals. Because macrophages are major producers of cytokines during sepsis, we compared cytokine responses by peritoneal macrophages from WT or IRAK1-deficient mice following stimulation by various TLR agonists in vitro (Fig. 4) . Ultrapure LPS and Pam3CSK4 were used as selective TLR4 and TLR2 activators, whereas thiazoloquinoline was employed to stimulate TLR7/TLR8-mediated responses. Figure 4 shows that after TLR4 activation, IL-6 and IL-1β responses were blunted in IRAK1-deficient macrophages as compared to WT (Fig. 4a and d) . IL-6 and IL-1β responses were also partially decreased following TLR7/8 activation in IRAK1 deficiency (Fig. 4c and f) . However, IL-6 and IL-1β production was similar after TLR2 stimulus in WT and IRAK1-deficient macrophages ( Fig. 4b and e) . IL-10 production was unaffected by IRAK1 deficiency after TLR4 or TLR2 stimulus; however, IL-10 production was lower in IRAK1-deficient than WT macrophages following TLR7/8 activation (Fig. 3g, h, and i) . In the presence of vehicle, cytokine production was negligible in WT or IRAK1-deficient macrophages (not shown). haplotype with an increased functional IRAK1 activity worsens outcome from sepsis and septic shock [31, 32] . Thus, our current findings, together with other independent studies [2, 9, 10, 13, [31] [32] [33] , support the notion that IRAK1-mediated signaling is a key component of the regulatory pathways, which have direct and determining roles in clinical outcome during inflammatory conditions. The observation that IRAK1 deficiency inhibited systemic cytokine responses only at the early phase of the septic response indicates that cellular activation is delayed initially; however, at later stages of sepsis, redundant signaling or other mechanisms may compensate for lack of IRAK1. Additionally, sepsis survival was markedly improved in IRAK1 deficiency despite the fact that the degree of inflammation, as assessed by blood, BM, spleen, and lung cytokine levels, was similar at the premortal (20 h) stage of sepsis. These observations suggest that the early phase of the septic response may be critical in determining outcome. This conclusion is in agreement with previous studies, which indicated that although IL-6 was not causative in mediating outcome, elevated blood IL-6 concentration measured at 6 h post-CLP was a good predictor of mortality [27, 28] .
The findings indicating delayed inflammation in IRAK1-deficient mice by reduced mobilization of circulating neutrophils and blunted splenic B cell depletion following sepsis are important because both neutrophils and B cells play important roles in sepsis pathology. Mobilization and infiltration of activated neutrophils contribute to sepsis-associated organ dysfunction and damage [34, 35] , whereas B cell depletion is an important component of septic immune paralysis [36] [37] [38] . Thus, the blunted mobilization of IRAK1-deficient neutrophils, together with lessened depletion of tissue-resident B cells, is a possible contributing mechanism resulting in improved sepsis survival of IRAK1-deficient subjects.
Our in vitro observations on isolated macrophages following the activation of different TLRs suggest an IRAK1-dependent interplay among various signaling pathways [8, 39] . The observed decrease in TLR4-mediated IL1β and IL-6 production in IRAK1 deficiency is in agreement with previous studies [4] . The lack of impact of IRAK1 deficiency on cytokine production following TLR2 stimulus indicates the presence of compensatory mechanisms independent of IRAK1 for TLR2-mediated IL-6 and IL1β production in macrophages [8, 40] . Polymicrobial sepsis is expected to activate multiple TLR signaling pathways; thus, the observation that IRAK1 deficiency delayed the onset of inflammation suggests that IRAK1 is important for early postsepsis signaling via TLR4 and TLR7/8, whereas the inflammatory response at the later stages of sepsis is driven by other TLR-dependent pathways or redundant signaling mechanisms. It remains to be elucidated whether the presence of alternative signaling mechanisms in IRAK1 deficiency is the result of modulated differentiation during development or, alternatively, the signaling pathways mediating the inflammatory response during polymicrobial sepsis are inherently redundant.
Efficient elimination of invading bacteria without harming the septic host requires a balanced inflammatory response. Thus, complete and broad inhibition of either pro-or anti-inflammatory components during the septic response is unlikely to benefit the host. In contrast, partial inhibition or delay in the onset of cell activation and associated inflammatory responses is likely to be advantageous in septic conditions. The fact that our observations indicated improvement in survival in IRAK1 deficiency even in the evident presence of redundant signaling mechanisms supports the notion that a partial inhibition or delay in the onset of cell activation is likely to be advantageous during septic conditions. In summary, our study indicates a positive effect of IRAK1 inhibition during a polymicrobial septic response, which is manifested in a delayed onset of inflammation and improved survival. Lack of IRAK1 signaling only partially alleviates inflammation due to the presence of redundant pathways following mixed TLR stimuli. These observations together with other animal [9, 10, 14, 15] and human studies [31, 32] support the notion that downregulation of cell activation through targeting IRAK1 may be beneficial in clinical conditions, which predisposes the host to subsequent septic complications.
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